Biovian Oy's second generation AAV platform will include Remedium Bio Inc.'s lead treatment candidate against...
With assets of €12m through a Series A financing, Dutch Vitestro NV aims to bring the world's first autonomous blood...
How to stop hard-to-diagnose, treatment-resistant microbial pathogens was discussed by experts from 13 countries at the...
Mediar Therapeutics (Cambridge, MA, USA), a company developing a portfolio of first-in-class therapies to treat...
The Berlin-Brandenburg capital region is one of the leading life science regions in Europe and a lot is being done to...
Synthetic Biology: Green new world
Nearly thirty years ago, Bill Gates commented that “DNA is like a com- puter program, but far more advanced than any software ever created.” That...
Bioprocessing
According to the latest CPHI Annual Survey, CDMOs will see a significant increase in demand for biologic therapy manufacturing. With the tailwinds of...